Merge Labs has emerged from stealth with $252 million in funding from OpenAI and others. It aims to use ultrasound to read from and write to the brain.
Aurora Therapeutics, cofounded by Nobel Prize–winning scientist Jennifer Doudna, plans to use gene editing and a new FDA regulatory pathway to commercialize treatments for rare diseases.
Researchers suggest that they have recovered sequences from ancient works and letters that may belong to the Renaissance genius.
Although wolf-canine interbreeding has been considered extremely rare, the latest research shows that many present-day canines carry a small amount of wolf genes.
WIRED spoke with DeepMind’s Pushmeet Kohli about the recent past—and promising future—of the Nobel Prize-winning research project that changed biology and chemistry forever.
Smartwatches are cool and all, but have you considered wearable neurotech?
Merge Labs, a brain-computer interface startup that seeks to read brain activity using ultrasound, is being spun out of Forest Neurotech, a Los Angeles nonprofit.
Science Corporation, founded by Neuralink’s first president, Max Hodak, has unveiled a prototype machine to extend the life of organs for longer periods.
The Austin-based startup will test its high-bandwidth device to help restore speech in people with extremely limited movement.
An experimental gene-editing therapy developed by Crispr Therapeutics is showing promise for treating heart disease.